Tonghua Dongbao Pharmaceutical Co., Ltd.

Tonghua Dongbao Pharmaceutical Co., Ltd.verified

600867.SS

Price:

$8.81

Market Cap:

$17.22B

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as insulin glargine, Insulin aspart, and insulin lispro; antidiabetic drugs; and oral hypoglycemic drugs, as well as Gan Shulin pens, blood glucose meters, and other medical devices. It offers building materials. The company has a strategic alliance with Adocia. Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Industry

Drug Manufacturers - General

IPO Date

1994-08-24

Stock Exchange

SHH

Ticker

600867.SS

The Enterprise Value as of December 2025 (TTM) for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is 16.50B

According to Tonghua Dongbao Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.50B. This represents a change of 8.68% compared to the average of 15.19B of the last 4 quarters.

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) Historical Enterprise Value (quarterly & annually)

How has 600867.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Tonghua Dongbao Pharmaceutical Co., Ltd. over the last ten years is 24.22B. The current 16.50B Enterprise Value has changed 6.71% with respect to the historical average. Over the past ten years (40 quarters), 600867.SS's Enterprise Value was at its highest in in the June 2018 quarter at 57.93B. The Enterprise Value was at its lowest in in the March 2025 quarter at 13.91B.

Quarterly (TTM)
Annual

Average

24.22B

Median

25.57B

Minimum

17.31B

Maximum

32.86B

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tonghua Dongbao Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 77.70%

Maximum Annual Enterprise Value = 32.86B

Minimum Annual Increase = -19.66%

Minimum Annual Enterprise Value = 17.31B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202417.33B-15.40%
202320.48B18.36%
202217.31B-19.66%
202121.54B-18.58%
202026.46B4.12%
201925.41B-10.08%
201828.26B-14.00%
201732.86B27.68%
201625.74B-4.13%
201526.85B77.70%

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) Average Enterprise Value

How has 600867.SS Enterprise Value performed in the past?

The current Enterprise Value of Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

18.37B

5-year avg

20.62B

10-year avg

24.22B

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) Enterprise Value vs. Peers

How is 600867.SS’s Enterprise Value compared to its peers?

Tonghua Dongbao Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (14.85B), greater than Zhejiang Jiuzhou Pharmaceutical Co., Ltd (13.90B), less than Apeloa Pharmaceutical Co.,Ltd (17.95B), less than Yifan Pharmaceutical Co., Ltd. (17.04B), less than China Resources Double-Crane Pharmaceutical Co.,Ltd. (18.36B), less than Andon Health Co., Ltd. (20.61B), greater than Beijing Aosaikang Pharmaceutical Co., Ltd. (14.52B), greater than Anhui Anke Biotechnology (Group) Co., Ltd. (16.15B), greater than Qingdao Baheal Medical Inc. (13.53B), greater than Zhejiang CONBA Pharmaceutical Co.,Ltd. (11.70B),

Build a custom stock screener for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tonghua Dongbao Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tonghua Dongbao Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Tonghua Dongbao Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?

What is the 3-year average Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?

What is the 5-year average Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)?

How does the current Enterprise Value for Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) compare to its historical average?